| Blepharitis
Blepharitis is a generic term for several types of eyelid inflammation usually surrounding the lid margin and eyelashes, including both infectious and non-infectious forms. Chronic blepharitis is often linked to an occupation that causes dirty hands, or poor hygiene in general. The presentation is typically bilateral. Symptoms vary but may include any or all of the following: itching, burning, scratchiness, foreign body sensation, excessive tearing and crusty debris around the eyelashes, especially upon waking. Visible ocular signs include lid erythema, collarettes (a fibrin crust encircling an eyelash), madarosis (missing lashes), trichiasis (an inturned lash), plugged meibomian glands, conjunctival injection and superficial punctate keratitis on the lower third of the cornea. There is often an associated conjunctivitis with papillary hypertrophy of the palpebral conjunctiva. PATHOPHYSIOLOGYThough many types of lid inflammation exist, only those that affect lipid secretions are considered blepharitis. The cause is either meibomianitis, seborrhea (excess sebum production), Staphylococcal infection, or some combination of the three. Excess lipid production by the meibomian glands is the most common form of seborrheic blepharitis, but the condition can also occur from overactive sebaceous glands of the scalp, eyebrows and face as well. The meibomian glands themselves are often inflamed, but not necessarily in all cases. Paradoxically, this excess oil production ultimately reduces the lipid layer of the tear film. How? The excess quantity of oil on the lid margin promotes the formation of a crusty debris in and around the meibomian glands which eventually clogs the meibomian orifices, or at the very least interferes with meibomian secretions. These oily deposits on the lid margin provide bacteria with an ideal environment for infestation and multiplication, so it's not surprising that indigenous Staphylococcal infection often accompanies and exacerbates seborrheic blepharitis. In infectious blepharitis, bacterial exotoxins called lipases break down the cholesterol compounds within the meibomian secretions. This frees fatty acids, which are directly toxic to the corneal epithelium, resulting in punctate epitheliopathy and inflammation. Disturbance to the lipid layer increases tear evaporation and subsequently promotes dry eye. MANAGEMENTThe mainstay of therapy is improved lid hygiene. This alone may enable you to control symptoms and prevent further complications. Eyelid scrubs using a mild, deodorant-free soap or tearless shampoo will resolve or ameliorate most cases. The treatment dissolves eyelash and skin debris that is often laden with bacteria. Commercially available lid scrubs include Ocu-clear, Lids and Lashes, Lid Wipes SPF and Lid Scrub. For moderate, severe or chronic cases, you may need to prescribe topical and/or oral medications. When choosing medications, consider these four factors:
Sulfa drugs (i.e., sulfacetamide) are the classic medications for treating Staphylococcal infection. These work by competitive inhibition of para-amino benzoic acid (PABA), which inhibits cellular processes of the bacteria. Today, despite a reputation for broad spectrum activity, sulfa-based medications are often ineffective because many organisms have developed resistance to sulfa drugs. In these cases, other acceptable preparations include gentamicin, tobramicin, erythromicin and neomycin, polymyxin B and bacitracin, prescribed BID/QID in either ointment or drop form. If there's excessive inflammation and/or discomfort, try using an antibiotic-steroid combination prescribed BID or QID, in either ointment or eye drop form. Acceptable choices include:
In recalcitrant cases, try oral tetracycline, 250 to 500mg, BID or QID. While this concentration is not bactericidal, it inhibits the bacterial production of lipases, which increases stability of the tear film. CLINICAL PEARLS
Other reports in this section |
Eyelids & Eyelashes | Conjunctiva & Sclera | Cornea
Uvea | Vitreous & Retina | Optic Nerve & Brain | Oculosystemic
Disease
Handbook Main Page